| Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography |
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | BPT | 20 | 55.000 | 20091005, Ott H
|
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | BPT | 20 | 65.000 | 20091121, Ebo DG
|
| 1.1 - Asymptomatic | 2014 | Belgium | IgE | 15 | 93.330 | 20140718, Faber MA
|
| 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 35.500 | 20131020, van Rhijn BD
|
| 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 17.140 | 20130605, Simon D
|
| 1.12 - Oral Allergy Syndrome | 2014 | Belgium | IgE | 38 | 94.740 | 20140718, Faber MA
|
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 28.130 | 20120528, Patelis A
|
| 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.000 | 20130912, Lacerda Araujo LM
|
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Belgium | IgE | 14 | 0.000 | 20140718, Faber MA
|
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
|
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 55.500 | 20140331, Rockmann H
|
| 1.6 - Anaphylaxis, Diagnosed | 2014 | Belgium | IgE | 37 | 37.840 | 20140718, Faber MA
|
| 10.1 - Normal Control | 2014 | Belgium | IgE | 15 | 0.000 | 20140718, Faber MA
|
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
|
| 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 1.000 | 20111214, Zheng YW
|
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 22.730 | 20091121, Ebo DG
|
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 81.080 | 20090826, Ebo DG
|
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Denmark | IgE | 21 | 81.000 | 20090406, Skamstrup Hansen K
|
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 20 | 30.000 | 20090406, Skamstrup Hansen K
|
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 21 | 95.000 | 20090406, Skamstrup Hansen K
|
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2004 | Spain | IgE | 26 | 3.800 | |
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Denmark | IgE | 20 | 100.000 | 20090406, Skamstrup Hansen K
|
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2002 | Denmark | IgE | 24 | 95.800 | |
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Spain | IgE | 17 | 18.000 | 20090406, Skamstrup Hansen K
|
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Switzerland | IgE | 20 | 100.000 | 20090406, Skamstrup Hansen K
|
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2002 | Switzerland | IgE | 19 | 94.700 | |
| 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 16.710 | 20120528, Patelis A
|
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2003 | Denmark / Switzerland | IgE (IB) | 17 | 94.100 | |
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2004 | Germany / Switzerland | IgE (IB) | 65 | 98.500 | |
Loading...
Cor a 1.0401
